CA SB39

Cosmetic safety: vaginal suppositories.

Passed Senate Akilah Weber Pierson (D)
Plain English Summary

California SB39 focuses on the safety of vaginal suppositories by amending existing health and safety regulations. The bill aims to ensure that these products meet specific safety standards to protect public health. It declares an urgency for the changes to take effect immediately.

Supporters Say

Supporters of SB39 would highlight the bill as a significant step towards enhancing consumer safety and ensuring that vaginal health products are rigorously regulated. They would emphasize the importance of protecting individuals from potentially harmful substances in cosmetic products, promoting overall public health.

Critics Say

Critics may argue that SB39 could impose unnecessary regulations on cosmetic products, potentially limiting consumer choices and increasing costs for manufacturers. They might also raise concerns about the urgency of the bill, suggesting that it may have been rushed through the legislative process without adequate public input.

Legislative Votes
Unfinished Business SB39 Weber Pierson Urgency Clause Concurrence
Senate · Sep 11, 2025
Passed
40
YEA
0
NAY
SB 39 Weber Pierson Third Reading Urgency By Irwin
A · Sep 8, 2025
Passed
78
YEA
0
NAY
SB 39 Weber Pierson Consent Calendar Second Day Regular Session
A · Jun 27, 2025
Passed
75
YEA
0
NAY
Do pass. To Consent Calendar
A · Jun 17, 2025
Passed
7
YEA
0
NAY
Consent Calendar 2nd SB39 Weber Pierson Urgency Clause
Senate · Mar 28, 2025
Passed
34
YEA
0
NAY
Do pass and be ordered to the Consent Calendar
Senate · Mar 19, 2025
Passed
8
YEA
0
NAY

Source: LegiScan roll call vote data.

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us

About This Analysis

This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the California State Legislature. Conflict-of-interest analysis for this bill is coming soon.